ACX is developing a new standard for precision agriculture technologies by providing sustainable, eco-friendly alternatives to chemical pesticides.
Hi everyone,
We are ACX! We’re two PhD’s in Biochemistry/Biophysics and Computer Science from the University of Cambridge and King’s College London developing a new type of therapy with applications in animal farming and agriculture. We have discovered a new molecular weapon to first provide more efficacious pest control measures.
👩🏼🔬Emmanouela Petsolari – Molecular Geneticist and Biochemist with 8 years of research experience in drug discovery and development (from leukemia, ovarian, and breast cancer as well as viral and bacterial infections).
👩🏼🔬 Melina Petsolari – Computer Scientist and Designer with extensive experience in HCI, AI, and healthcare developing hardware and software for applications in digital health, biotech, and privacy.
There is more disease impacting our livestock and crops than ever before - and this comes at a time when the human population is also exploding.
Manure from livestock and extensive use of limited therapeutics for growth promotion and disease prevention in animal breeding as well as overuse of pesticides in crops
● One billion kilos of chemicals are used annually to combat crop pests
Spread of pathogenic agents that have adapted in previously used medications
Failure of commonly used pesticides and insecticides has been documented in nearly 1000 distinct pest species worldwide
● This leads each year to the world’s food supply facing an up to 30% loss due to insect pests alone, and this number is continuously increasing
Existing therapeutics are either no longer effective or have never worked to the extent necessary for achieving positive outcomes. We have discovered a common biological pathway that can be targeted across pathogenic species.
Illustration of our solution. Nanoparticles carrying the killer compound (orange) infiltrate the target cell like a Trojan horse and activate drug release upon targeting our newly discovered pathway.
➔ High killing efficacy
➔ Designed to specifically target pathogenic cells while preserving the surrounding healthy cells and ensuring no toxicity or adverse side effects
➔ Highly suitable to become a platform solution (i.e., therapeutic development pipeline expanded to multiple disease areas and organisms)
➔ Scalable, stable, and easy to manufacture